Artificial Intelligence (AI) platforms Could Enhance Jaguar Health’s development and anticipated commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
April 14, 2026
Host Johnathan Miller interviews Board Director & CEO, Nancy Lurker, who shares some management information as well as some of their products insights.